We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Greiner Bio-One

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
14 Jul 2020 - 14 Jul 2020
Virtual Venue
15 Jul 2020 - 19 Jul 2020
Virtual Venue

Illustration

Artificial Intelligence Helps Identify T-cell Targets for Development of SARS-CoV-2 Vaccine

A neoantigen prediction platform that employs state-of-the-art bioinformatics and artificial intelligence (AI) to identify an optimal set of neoantigens as targets for cancer vaccines or adoptive cell therapies is being used for the development of a SARS-CoV-2 vaccine. More...
10 Jul 2020
Illustration

Synthetic Nanobodies Offer Potential for Development of Inhalable COVID-19 Drugs

Synthetic nanobodies against the receptor binding domain (RBD) of SARS-CoV-2 hold particular promise for the development of inhalable drugs, which could offer a convenient treatment option for COVID-19. More...
10 Jul 2020
Image: EpiGentek Launches First-to-Market Kits to Detect SARS-CoV-2-Targeted Furin Activity and Screen for Inhibitors against COVID-19 (Photo courtesy of EpiGentek)

EpiGentek Launches First-to-Market Kits to Detect SARS-CoV-2-Targeted Furin Activity and Screen for Inhibitors Against COVID-19

EpiGentek (Farmingdale, NY, USA) has released a series of SARS-CoV-2 research assays that focuses on studies of SARS-CoV-2 targeted furin or proprotein convertase (PC) cleavage activity. More...
10 Jul 2020
Image: Triple Antibody Test for COVID-19 Provides Laboratory-Standard Results in Just Seven Minutes (Photo courtesy of Attomarker Ltd.)

Triple Antibody Test for COVID-19 Provides Laboratory-Standard Results in Just Seven Minutes

 A new triple antibody test detects antibodies to three different COVID-19 proteins in seven minutes at the PoC, giving a more powerful profile of the clinically relevant biomarkers than other currently available COVID-19 tests. More...
10 Jul 2020
Illustration

Gilead Begins Testing Inhaled Version of Remdesivir for Treatment of COVID-19

Gilead Sciences, Inc. (Foster City, CA, USA) has initiated clinical testing of an inhaled solution of remdesivir for potential outpatient treatment of COVID-19. More...
10 Jul 2020
Image: China’s Sinovac Biotech Begins Phase 3 Trials of Coronavirus Vaccine Candidate in Brazil (Photo courtesy of Sinovac Life Sciences Co., Ltd.)

China’s Sinovac Biotech Begins Phase 3 Trials of Coronavirus Vaccine Candidate in Brazil

The Brazilian national regulatory agency, Anvisa, has granted approval to a phase 3 clinical trial to test efficacy and safety of the inactivated COVID-19 vaccine developed by Sinovac Life Sciences Co., Ltd. (Beijing, China). More...
10 Jul 2020
Illustration

Common Antihistamine Nasal Spray Identified as Potential Anti-COVID-19 Drug

Azelastine, an antihistamine currently available as a nasal spray, has been identified as a potential topical preventive or post-exposure anti-COVID-19 approach. More...
10 Jul 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.